Respiratory medicine (lung)
Spoken Languages


Dr Samantha Kon qualified at University College London Medical School in 2002 and went on to train in respiratory and general internal medicine in London, including Royal Brompton & Harefield NHS Foundation Trust and Imperial College Healthcare NHS Trust. 

Dr Kon undertook three years of research training in COPD and was awarded a PhD in 2015. She also holds a postgraduate certificate in allergy. 

Areas of expertise

Dr Kon is a general chest physician with specialist training in: 

  • chronic obstructive pulmonary disease (COPD)
  • respiratory failure
  • sleep disordered breathing 
  • domiciliary nocturnal ventilation 
  • allergy. 

She is based at both Harefield and Hillingdon Hospitals and sees patients with advanced COPD, respiratory failure and sleep disorders at Harefield Hospital. 

At Hillingdon Hospital, Dr Kon is responsible for the development of integrated care services and is lead for COPD and non-invasive ventilation. 


Dr Kon conducts research into the use of simple functional outcome measures and health-related quality of life instruments in COPD and pulmonary rehabilitation. 

She has been an invited lecturer at major national respiratory conferences. Her research on her thesis 'Habitual gait speed: A novel Prognostic marker in COPD?' was funded by the Medical Research Council. 

Dr Kon was awarded first prize for Best Abstract in Rehabilitation and Chronic Care at the European Respiratory Society Congress in 2013. 


Dr Kon has published papers and abstracts in major respiratory and general medical journals. She also regularly acts as an expert reviewer for: 

  • American Journal of Respiratory and Critical Care Medicine
  • Thorax
  • European Respiratory Journal
  • Chest
  • Respiratory Medicine
  • Primary Care Respiratory Medicine
  • Chronic Respiratory Disease
  • International Journal of COPD. 


Research Publications


Hospitalisation for acute exacerbations of COPD is associated with high risk of readmission.

In community-dwelling older adults, usual gait speed over 4 m (4MGS) consistently predicts greater risk of adverse health outcomes.